Akela Pharma Inc.
Description Akela Pharma, Inc. operates as a specialty contract pharmaceutical formulation developer in the United States. It offers contract pharma services comprising formulation and process development of drug in tablets, capsules, multiparticulates, fast formulations, oral and topical liquids, powders for suspension/reconstitution, and semi-solid forms. The company also provides analytical services, which include research and development analytical testing and support for formulation development; analytical method development and phase-appropriate validation; quality control testing for API and raw materials release; and stability testing and ICH compliant stability storage. In addition, it offers drug delivery solutions, such as hot melt extrusion for amorphous dispersions, spray-drying for amorphous dispersions, controlled release dosage forms, liquid solutions (encapsulated and bottled), and novel dosage forms, as well as beads, granulation, and drug layering services. Further, the companys contract services consist of handling of potent compounds; pharmaceutical patent litigation support services; GMP clinical and commercial manufacturing; clinical labeling and packaging; and IP validation and contestation consulting services. The company was formerly known as LAB International Inc. and changed its name to Akela Pharma, Inc. in June 2007. Akela Pharma, Inc. was founded in 1979 and is headquartered in Austin, Texas. To view the detailed information, you need to SUBSCRIBE with us. |
 |